High Notes Investors Group (HNIG)
Press Release
_______________________________
23 October 2008
1. We are a group of DBS High Notes (HN) investors that has been formed to communicate with DBS and undertake relevant collective actions against the bank where and when necessary.
2. On Wednesday 22nd October 2008, we have submitted a petition letter to DBS urging them to convene a meeting with our group of HN investors. At the time of the submission, three of our representatives also met with Mr Rajan Raju the Head of DBS’s Consumer Banking Group. Our group wants DBS to:
a) Provide all HNs investors with a detailed statement of account for each series of the High Notes
b) To hold a meeting of the investors to give an explanation on the performance of each series of the High Notes and to allow us ask questions and seek clarification. The group also requested the presence of the 2 independent consultants.
Mr Rajan welcomed the move, and he said DBS would quickly look at fulfilling the request.
3. With regards to the DBS offer of $80m to be made to some HN5 investors, we feel there is too little information released to judge if the offer is fair. However, we would like to put these questions and comments to DBS:
a) What percentage of the $80m is earmarked for Hong Kong investors?
b) When will DBS make similar offers to the investors outside of the 'vulnerable' group?
c) How will DBS handle the cases of investors who have funds in other High Notes series?
d) DBS should resolve all HN cases expeditiously
4. Our group currently has 230 investors in our contact list and this consists of investors of various HNs and representing close to $15 million.
5. For any clarifications, please contact dbs.hns@gmail.com.
================== E N D ==============
.
Sunday, October 26, 2008
Subscribe to:
Post Comments (Atom)
2 comments:
I am an HN3 investor but I have not registered for this forum. Could I suggest that the HN5 and HN2 groups raise the following issues with DBS Management at the coming forum:
Is there any product risk assessment done by the bank before the product is marketed to the investors? If so, what is the conclusion of the assessment, is it high or low risk and whether adequate disclosure is made to investors through the RMs?
Depending on the answers to these questions, it may help to prove our claims of misrepresentation or mis-selling.
Though I am actively involve in stock market, I told my RM I will not invest in risky product in the bank. The bank is supposed to keep my safe money.
When she sold me the HN2, she told me that the risk profile has to be changed because the conservative investor will not be allowed to buy this product because there is a risk in this product, but the risk is limited because the product is "diversified"into 8 entities, and should one of them fail, the product will be terminated and I could lose 1/8 of the capital.I agree to the change in my risk profile because I could take the risk of losing 1/8 of my capital. So the risk profile is changed to growth.
Post a Comment